A new screening test can detect colorectal cancer with a simple blood draw in people with an average risk of the cancer.
The test can detect early-stage colorectal cancer with a sensitivity of 93%, according to mid-stage data shared by the test maker, Universal DX, in May. The test can also detect the pre-cancerous growths with 54% sensitivity.
Colonoscopies are the gold standard for colorectal cancer screening. Not only can a provider find and diagnose cancerous growths, but they can also remove pre-cancerous polyps.